About Us  |  Contact Us  |  Español
Butler Hospital
Butler Hospital

Organizations Butler
Research Type Clinical
Therapeutic Area of Study Parkinson's Disease/Movement Disorders
Eligibility Criteria Male or female subjects over the age of 40 with Parkinson’s disease and psychotic symptoms that developed after the diagnosis of PD that include; visual hallucinations and/or auditory hallucinations and/or delusions
Recruitment Status Open
Date Study Started 08/01/2010
Date Study Ends 08/01/2015
Contact Information

 For more information contact Lisa at 401-455-6667

Description The purpose of this study is to investigate the safety of Pimavanserin in the treatment of psychosis in Parkinson’s disease. The study is weeks long with 6 visits over the course of that time with the option to participate in an open-label extension study.
Look for another study
Health Headlines
Combination Antibiotic Zerbaxa ApprovedView in a lightbox
Bone Drugs May Protect Against Endometrial CancerView in a lightbox
Certain Antibiotic/Statin Combos May Be Unsafe Mix: StudyView in a lightbox
Health Highlights: Dec. 22, 2014View in a lightbox
Health Tip: Finding Time for FitnessView in a lightbox
Butler Hospital
© 2011 Site Index | Disclaimer | Legal Notices | Talks Your Health